Cargando…
P1392: INTERIM ANALYSIS OF FIRST IN HUMAN PHASE I-II CLINICAL TRIAL OF EX-VIVO GENE THERAPY FOR HURLER SYNDROME: AN UPDATE AT 3 YEAR FOLLOW-UP
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430690/ http://dx.doi.org/10.1097/01.HS9.0000972456.19958.59 |
_version_ | 1785091026906513408 |
---|---|
author | Tucci, Francesca Consiglieri, Giulia Filisetti, Chiara De Pellegrin, Maurizio Mellone, Renata Fumagalli, Francesca Darin, Silvia Sarzana, Marina Scarparo, Stefano Ciotti, Francesca Silvani, Paolo Baldoli, Cristina Pontesilli, Silvia Parini, Rossella la Marca, Giancarlo Ciceri, Fabio Naldini, Luigi Aiuti, Alessandro Gentner, Bernhard Ester Bernardo, Maria |
author_facet | Tucci, Francesca Consiglieri, Giulia Filisetti, Chiara De Pellegrin, Maurizio Mellone, Renata Fumagalli, Francesca Darin, Silvia Sarzana, Marina Scarparo, Stefano Ciotti, Francesca Silvani, Paolo Baldoli, Cristina Pontesilli, Silvia Parini, Rossella la Marca, Giancarlo Ciceri, Fabio Naldini, Luigi Aiuti, Alessandro Gentner, Bernhard Ester Bernardo, Maria |
author_sort | Tucci, Francesca |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10430690 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104306902023-08-17 P1392: INTERIM ANALYSIS OF FIRST IN HUMAN PHASE I-II CLINICAL TRIAL OF EX-VIVO GENE THERAPY FOR HURLER SYNDROME: AN UPDATE AT 3 YEAR FOLLOW-UP Tucci, Francesca Consiglieri, Giulia Filisetti, Chiara De Pellegrin, Maurizio Mellone, Renata Fumagalli, Francesca Darin, Silvia Sarzana, Marina Scarparo, Stefano Ciotti, Francesca Silvani, Paolo Baldoli, Cristina Pontesilli, Silvia Parini, Rossella la Marca, Giancarlo Ciceri, Fabio Naldini, Luigi Aiuti, Alessandro Gentner, Bernhard Ester Bernardo, Maria Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430690/ http://dx.doi.org/10.1097/01.HS9.0000972456.19958.59 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Tucci, Francesca Consiglieri, Giulia Filisetti, Chiara De Pellegrin, Maurizio Mellone, Renata Fumagalli, Francesca Darin, Silvia Sarzana, Marina Scarparo, Stefano Ciotti, Francesca Silvani, Paolo Baldoli, Cristina Pontesilli, Silvia Parini, Rossella la Marca, Giancarlo Ciceri, Fabio Naldini, Luigi Aiuti, Alessandro Gentner, Bernhard Ester Bernardo, Maria P1392: INTERIM ANALYSIS OF FIRST IN HUMAN PHASE I-II CLINICAL TRIAL OF EX-VIVO GENE THERAPY FOR HURLER SYNDROME: AN UPDATE AT 3 YEAR FOLLOW-UP |
title | P1392: INTERIM ANALYSIS OF FIRST IN HUMAN PHASE I-II CLINICAL TRIAL OF EX-VIVO GENE THERAPY FOR HURLER SYNDROME: AN UPDATE AT 3 YEAR FOLLOW-UP |
title_full | P1392: INTERIM ANALYSIS OF FIRST IN HUMAN PHASE I-II CLINICAL TRIAL OF EX-VIVO GENE THERAPY FOR HURLER SYNDROME: AN UPDATE AT 3 YEAR FOLLOW-UP |
title_fullStr | P1392: INTERIM ANALYSIS OF FIRST IN HUMAN PHASE I-II CLINICAL TRIAL OF EX-VIVO GENE THERAPY FOR HURLER SYNDROME: AN UPDATE AT 3 YEAR FOLLOW-UP |
title_full_unstemmed | P1392: INTERIM ANALYSIS OF FIRST IN HUMAN PHASE I-II CLINICAL TRIAL OF EX-VIVO GENE THERAPY FOR HURLER SYNDROME: AN UPDATE AT 3 YEAR FOLLOW-UP |
title_short | P1392: INTERIM ANALYSIS OF FIRST IN HUMAN PHASE I-II CLINICAL TRIAL OF EX-VIVO GENE THERAPY FOR HURLER SYNDROME: AN UPDATE AT 3 YEAR FOLLOW-UP |
title_sort | p1392: interim analysis of first in human phase i-ii clinical trial of ex-vivo gene therapy for hurler syndrome: an update at 3 year follow-up |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430690/ http://dx.doi.org/10.1097/01.HS9.0000972456.19958.59 |
work_keys_str_mv | AT tuccifrancesca p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup AT consiglierigiulia p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup AT filisettichiara p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup AT depellegrinmaurizio p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup AT mellonerenata p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup AT fumagallifrancesca p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup AT darinsilvia p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup AT sarzanamarina p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup AT scarparostefano p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup AT ciottifrancesca p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup AT silvanipaolo p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup AT baldolicristina p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup AT pontesillisilvia p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup AT parinirossella p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup AT lamarcagiancarlo p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup AT cicerifabio p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup AT naldiniluigi p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup AT aiutialessandro p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup AT gentnerbernhard p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup AT esterbernardomaria p1392interimanalysisoffirstinhumanphaseiiiclinicaltrialofexvivogenetherapyforhurlersyndromeanupdateat3yearfollowup |